http://www.theaustralian.com.au/business/opinion/westfields-wdc-1209-may-struggle-to-raise-35bn-amid-qr-share-sale/story-e6frg9if-1225952309361
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%